NFIL3 and glioma: We investigated the relevance of the three-TF signature to regulation mechanisms of glioma carcinogenesis and suggested AHR, NFIL3 and ZNF423 as promising biomarkers for not only glioma molecular subtype diagnosis but also clinical treatment.